About: TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company provides Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts.
Sector: Healthcare
Industry: Medical Devices
Latest price: $70.74 (-1.83%)
TMDX NASDAQ TransMedics Group Inc
TransMedics Group Inc share price
Atividade de preço de TMDX
Último preço
$ 70,740
Variação (24h)
-1,32 USD (1,83%)
Volume
749.79K
Volume (média 4 sem.)
-
Abertura
$ 71,42
Variação do dia
$ 69,76 - $ 72,63
Fechamento anterior
$ 72,06
Último negócio
23 Oct, 8:00 pm GMT+0
Atrasado
23 Oct, 8:00 pm GMT+0
TMDX price performance
Atrasado
23 Oct, 8:00 pm GMT+0
quote.marketSignals